Privia Health Group, Inc. (PRVA) Stock Analysis

Company Overview

Privia Health Group, Inc. (PRVA) is capitalised at $2.64B on the latest close. It is classified in the Health Information Services industry, within the Healthcare sector. The company reports 1,226 employees.

The most recent close on file for PRVA is $20.66, dated September 4, 2026. That is −$0.01 (−0.05%) against the previous close. The 52-week range on file runs from $19.53 to $28.82. The latest close sits 5.79% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $2.12B. That is +22.26% against the prior fiscal year, when revenue was $1.74B. Net income for the same year was $22.92M. That is +59.33% against the prior fiscal year. The reported profit margin is 1.19%. That is 1.2 percentage points above the Health Information Services median of 0%. Earnings per share on a trailing basis come to 0.22.

Across the 4 fiscal years on file, revenue moves from $1.36B in 2022 to $2.12B in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

PRVA trades at a trailing price-to-earnings ratio of 93.91. That is 128.32% above the Health Information Services median of 41.13. On forward earnings the ratio is 19.43. The price-to-sales ratio is 1.12. On price-to-sales that is 57.91% below the Health Information Services median of 2.66. 53 Health Information Services companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is −10.64%. Measured over 5 years, that is −8.40% a year compounded. The reported beta is 0.88. Daily returns over the trailing 5 years annualize to a volatility of 47.66%.

Growth & Income

The record shows no dividend for PRVA.

Across the complete calendar years on file, 2025 returned +21.28% and 2024 returned −15.11%. Of the 4 complete calendar years on file, 2 finished higher. 2026 is still running; the price is −12.86% year to date.